Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  News  >  Business Leaders  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
HomeAll newsMost read newsBusiness Leaders Biography
Portrait de Daniel L. Flynn
Age : 2018
Public asset : 3,868,430 USD
Linked companies : Deciphera Pharmaceuticals, Inc.
Founder of Deciphera Pharmaceuticals, Inc. and Deciphera Pharmaceuticals LLC, Daniel L. Flynn currently occupies the position of Chief Scientific Officer for Deciphera Pharmaceuticals, Inc. and Director & Chief Scientific Officer at Deciphera Pharmaceuticals LLC (a subsidiary of Deciphera Pharmaceuticals, Inc.).

He is also on the board of University of Kansas Center for Research, Inc. and Professor at the University of Kansas.

In his past career Daniel L. Flynn occupied the position of Director-Medicinal Chemistry at Amgen, Inc., Principal at Warner-Lambert Co., Senior Director-Chemistry at Takeda Oncology Co., Director-Medicinal Chemistry at Monsanto Co., Principal at G.D. Searle & Co., Inc., Principal at Parke-Davis Pharmaceutical Research, Inc. and Chairman-Medicinal Chemistry Division at American Chemical Society.

He received a doctorate from the University of Kansas.

Current positions of Daniel L. Flynn 
NameTitle Since
Deciphera Pharmaceuticals, Inc.
(Biotechnology & Medical Research)
Chief Scientific Officer 2014
Deciphera Pharmaceuticals LLC Director & Chief Scientific Officer 2014
University of Kansas Center for Research, Inc. Trustee -
University of Kansas Professor -

Holdings of Daniel L. Flynn 
Deciphera Pharmaceuticals, Inc. (DCPH)
(Biotechnology & Medical Research)
146,5490.30%5,316,798 USD

Daniel L. Flynn: Personal Network 

Most Read News 
10/16CARLOS SLIM : Mexican billionaire Slim vows to invest in Mexico, touting economic prospects
10/15WARREN BUFFETT : Buffett's Berkshire seeks Fed leeway to boost BofA bet - Fed
10/15DAVID CALHOUN : Boeing Turns to a Crisis Pro to Lead Board -- WSJ
10/19MARK HURD : Oracle Co-CEO Mark Hurd Dies at 62 -- WSJ
10/18MARK HURD : Oracle co-CEO Mark Hurd dies at 62
10/17MARC BENIOFF : Marc Benioff of Salesforce Sounds Alarm on Technology
10/18LARRY ELLISON : Oracle Says Co-CEO Mark Hurd Has Died -- Update
10/18JAMIE DIMON : JPMorgan's Dimon says Facebook's Libra currency 'will never happen'
10/20MARK ZUCKERBERG : Warren takes swipe at Mark Zuckerberg over political ads
10/18MARK ZUCKERBERG : Zuckerberg Rejects Calls for Controls -- WSJ
More news

© 2019 People and Ownership :   
Daniel L. Flynn : Connections 
Rempex Pharmaceuticals, Inc.
The Rockefeller University
Adimab LLC
Link Medicine Corp.
Americo Life, Inc.
Frazier Management LLC
Erasca, Inc.
Cadent Therapeutics, Inc.
Gordon Research Conferences
Formfox, Inc.
Clinical Reference Laboratory, Inc.
Harvard Medical School
Mount Desert Island Hospital, Inc.
Thesan Pharmaceuticals, Inc.
Advantagene, Inc.

Popular Business Leaders 
Paul Achleitner Bernard Arnault Jeff Bezos Vincent Bolloré Martin Bouygues Warren Buffett Fulvio Conti Tim Cook Michael Dell Herbert Diess Jamie Dimon Jack Dorsey Sergio Ermotti Guillaume Faury Carlos Ghosn Philip Green David Henry John Hess Mark Hurd Carl Icahn Robert Iger Li Ka-shing Guido Kerkhoff Jack Ma Martina Merz Lakshmi Mittal Dennis Muilenburg Rupert Murdoch Elon Musk Jean-pierre Mustier Alexander Novak Michael O'leary Ferdinand Piëch Patrick Pouyanné Sumner Redstone Alexandre Ricard Stéphane Richard Urs Rohner Wilbur Ross Hiroto Saikawa Charles Scharf Jean-dominique Senard Christian Sewing Martin Sorrell Friede Springer Carlos Tavares Tidjane Thiam Devin Wenig Mark Zuckerberg
A-Z Business Leaders